Ajanta Pharma Ltd 532331
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 2,079.70
- Day Range
- INR 2,063.45–2,103.50
- 52-Week Range
- INR 1,240.55–2,355.05
- Bid/Ask
- INR 0.00 / INR 0.00
- Market Cap
- INR 262.12 Bil
- Volume/Avg
- 1,788 / 2,732
Key Statistics
- Price/Earnings (Normalized)
- 35.00
- Price/Sales
- 6.58
- Dividend Yield (Trailing)
- 1.73%
- Dividend Yield (Forward)
- 1.73%
- Total Yield
- 3.21%
Company Profile
Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintains a global presence while generating the vast majority of its revenue in Africa and India. Ajanta's strategy aims to successfully select molecules and products for development while enhancing its research and development capabilities. The company works to develop formulations in different dosages such as tablets, cream, capsules, liquid, and lotion. The company's manufacturing plants are located in India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 7,713
- Website
- https://www.ajantapharma.com
Comparables
Valuation
Metric
|
532331
|
TORNTPHARM
|
533573
|
---|---|---|---|
Price/Earnings (Normalized) | 35.00 | 59.59 | 33.82 |
Price/Book Value | 7.52 | 12.85 | 4.24 |
Price/Sales | 6.58 | 8.35 | 3.18 |
Price/Cash Flow | 32.81 | 37.32 | 24.53 |
Price/Earnings
532331
TORNTPHARM
533573
Financial Strength
Metric
|
532331
|
TORNTPHARM
|
533573
|
---|---|---|---|
Quick Ratio | 2.06 | 0.55 | 0.72 |
Current Ratio | 3.21 | 1.08 | 1.73 |
Interest Coverage | 144.83 | 6.63 | 10.47 |
Quick Ratio
532331
TORNTPHARM
533573
Profitability
Metric
|
532331
|
TORNTPHARM
|
533573
|
---|---|---|---|
Return on Assets (Normalized) | — | — | — |
Return on Equity (Normalized) | — | — | — |
Return on Invested Capital (Normalized) | — | — | — |
Return on Assets
532331
TORNTPHARM
533573
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Fbdtnnmy | Nwgt | $70.0 Bil | |
MKKGY
| Merck KGaA ADR | Pjjfgjxdx | Gxxnz | $68.1 Bil | |
HLN
| Haleon PLC ADR | Cctsvdcg | Szyzm | $36.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Gnpxkyks | Ynbzk | $14.3 Bil | |
VTRS
| Viatris Inc | Mjtskmlt | Tsj | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Msykbzn | Mmwzs | $11.9 Bil | |
CTLT
| Catalent Inc | Pkjqwqnr | Gtgvgbn | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Srdlxdrqj | Ptt | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Ntklkzrz | Wpy | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Jvnlffvf | Vpctnm | $3.4 Bil |